Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000766

Type of data
NGS (RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
3.3 TB
File formats
  • FASTQ
Research
hum0423
Date published
2024-10-24
Date modified
2024-12-26
DDBJ Search
JGAD000766 (opens in a new tab)
JGA Study
JGAS000636 (opens in a new tab)

Analysis method

RNA-seq

Materials and participants
sarcoid myopathy (ICD10: D86.8, G73.7): 22 cases (22 samples)
Short read RNA sequencing: 16 cases (16 samples)
Long read RNA sequencing: 6 cases (6 samples)
Muscular disease (non-sarcoid myopathy): 400 controls (400 samples)
Short read RNA sequencing: 400 controls (400 samples)
  • Health status
    Affected
  • Subject count
    422 (Individual)
Disease
sarcoid myopathy (D868, G737)
Sample description
RNAs extracted from muscular lesions
  • Tissue
    Muscle
  • Tumor / normal
    Normal
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
cDNA-PCR Sequencing Kit
Fragmentation
MGI: Reverse transcription by random priming
Nanopore: -
Platform
MGI DNBSEQ-G400
Oxford Nanopore Technologies PromethION
Read type
Mixed
Read length
MGI: 100 bp
Nanopore: 918 bp (Mean)
Data use policy
NBDC data sharing policy (JGAP000001)

snRNA-seq

Materials and participants
sarcoid myopathy (ICD10: D86.8, G73.7): 2 cases (2 samples)
1 case is also used in RNA-seq
  • Health status
    Affected
  • Subject count
    2 (Individual)
Disease
sarcoid myopathy (D868, G737)
Sample description
RNAs extracted from muscular lesions
  • Tissue
    Muscle
  • Tumor / normal
    Normal
Sample provider
N/A
Experimental method
scRNA-seq
Target
N/A
Reagent kit
Chromium Next GEM Single Cell 3' v3.1
Fragmentation
Enzymatic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
100 bp
Data use policy
NBDC data sharing policy (JGAP000001)